Skip to main content
. 2016 Jan 11;33(3):413–421. doi: 10.1007/s10815-015-0633-9

Table 3.

Clinical outcomes according to the group

HPC 95 % CI SSS 95 % CI
Number of embryo transfers 196 (89.9) (85.9–93.9) 188 (87.8) (83.1–92.2)
Number of transfers on day 3 108 (55.1) (48.1–62.1) 123 (65.4) (58.6–72.2)
Number of transfers on blastocyst stage 88 (44.9) (37.9–51.9) 65 (34.6) (27.8–41.4)
Number of embryos replaced (mean ± SD) 362 (1.8 ± 0.4) (1.7–1.9) 345 (1.8 ± 0.4) (1.7–1.8)
Number of cycles with embryo cryopreservation 171/218 (78.4) (72.9–83.9) 160/214 (74.8) (69.0–80.6)
Number of re-vitrified embryos (mean ± SD) 549 (3.2 ± 1.9) (2.9–3.5) 471 (2.9 ± 1.8) (2.6–3.2)
Implantation rate 155/362 (42.8) (37.7–47.9) 142/345 (41.2) (36.0–46.4)
Clinical pregnancy rate/cycle 119/218 (54.6) (48.0–61.2) 106/214 (49.5) (42.8–56.2)
Clinical pregnancy rate/embryo transfer 119/196 (60.7) (53.9–67.5) 106/188 (56.4) (49.3–63.5)
Ongoing pregnancy rate/cycle 95/218 (43.6) (37.0–50.2) 87/214 (40.6) (34.0–47.2)
Ongoing pregnancy rate/embryo transfer 95/196 (48.5) (41.5–55.5) 87/188 (46.3) (39.2–53.4)
Miscarriage rate 21/119 (17.6) (10.8–24.4) 19/106 (17.9) (10.6–25.2)
DR/cycle 81/218 (37.2) (30.8–46.6) 79/214 (36.9) (30.4–43.4)
LBR/cycle 96/218 (44) (37.4–50.6) 97/214 (45.3) (38.6–52)

Unless otherwise indicated, values are mean ± SD or n (%) with 95 % confidence limits in brackets